Advisor Group Holdings, Inc. Medicenna Therapeutics Corp. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.28 - $0.51 $49 - $89	-176 Reduced 0.79%	22,000 $6,000
Q1 2022 May 04, 2022	BUY	$1.26 - $1.92 $3,150 - $4,800	2,500 Added 12.71%	22,176 $96,000
Q3 2021 Nov 05, 2021	BUY	$1.91 - $3.05 $32,470 - $51,850	17,000 Added 635.28%	19,676 $54,000
Q2 2021 Aug 02, 2021	BUY	$2.97 - $4.28 $1,485 - $2,140	500 Added 22.98%	2,676 $9,000
Q1 2021 May 13, 2021	BUY	$3.5 - $4.56 $7,000 - $9,120	2,000 Added 1136.36%	2,176 $9,000
Q4 2020 Feb 10, 2021	BUY	$3.7 - $5.97 $651 - $1,050	176 New	176 $1,000

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.